X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/03/2857002/7281/en/XOMA-Corporation-Announces-Closing-of-Tender-Offer.html
https://www.globenewswire.com/news-release/2024/03/19/2848966/7281/en/XOMA-Announces-Calculation-of-Additional-Price-Per-Share-and-Extension-of-Expiration-Date-for-Tender-Offer-for-Kinnate-Biopharma-Inc.html
https://www.globenewswire.com//news-release/2024/03/01/2838802/0/en/Kinnate-Biopharma-Inc-Sells-Its-Investigational-Pan-RAF-Inhibitor-Exarafenib-to-Pierre-Fabre-Laboratories.html
https://www.prnewswire.com/news-releases/kinnate-biopharma-inc-sells-its-investigational-pan-raf-inhibitor-exarafenib-to-pierre-fabre-laboratories-302076211.html
https://www.globenewswire.com//news-release/2024/02/16/2830729/7281/en/XOMA-Enters-into-Agreement-to-Acquire-Kinnate-Biopharma-for-Between-2-3352-and-2-5879-in-Cash-Per-Share-Plus-a-Contingent-Value-Right.html
https://www.globenewswire.com//news-release/2023/11/09/2777793/0/en/Kinnate-Biopharma-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Updates.html
https://www.fiercebiotech.com/biotech/kinnate-lays-70-staff-pulls-back-programs-save-cash-after-data-disappointment
https://www.globenewswire.com//news-release/2023/09/18/2745187/0/en/Kinnate-Biopharma-Inc-Announces-Pipeline-Updates-Strategic-Reprioritization-and-Workforce-Restructuring.html
https://www.globenewswire.com/news-release/2023/08/08/2721144/0/en/Kinnate-Biopharma-Inc-Reports-Second-Quarter-2023-Financial-Results-and-Recent-Corporate-Updates.html
https://www.globenewswire.com/news-release/2023/06/01/2680813/0/en/Kinnate-Biopharma-Inc-to-Participate-in-Upcoming-Investor-Conferences.html
Market Place
Share 
